This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Dion's Weekly ETF Winners and Losers

NEW YORK ( TheStreet) -- Here are this week's winners and losers.

Winners

iPath S&P 500 VIX Short Term Futures ETN (VXX) (VXX) 8%

The market's rally at the end of the week caused VXX to give back a portion of its gains. The losses were not enough to offset the ETN's strength entirely. On the contrary, it still managed to score a spot near the top of this week's winners list.

Heading into next week, VXX is in the process of testing its 50-day moving average. This is the first time this level has been visited since its initial ascension in early August. Many of the same factors that have sparked investor concerns in recent months remain in play. It will be interesting to see if VXX can remain buoyed here.

iShares Dow Jones U.S. Home Construction Index Fund (ITB) 7.4%

A strong batch of data and an optimistic report from the National Association of Homebuilders helped to propel homebuilder-related ETFs higher. ITB and the SPDR S&P Homebuilder ETF (XHB) have enjoyed impressive action over the course of the month.

Real estate will again be in focus next week as investors anticipate the release of new and pending home sales reports.

Although homebuilders appear promising, investors should continue to steer clear. The housing market remains muddled in uncertainty. Those looking for a safer bet on this sector should turn to a REIT-focused fund like the iShares Cohen & Steers Realty Majors Fund (ICF).

iShares MSCI Israel Capped Investable Market Index Fund (EIS) 4.4%

The Israel ETF has had a rough couple of months. As global macroeconomic concerns have driven investors out of international markets, shares of EIS have tumbled hard. At the end of September, the fund had retreated to levels seen during the middle of 2009.

In October, however, it appears as though the nation's marketplace has found some footing.

Investors interested in venturing into EIS should exercise caution. The fund's index is dominated by two companies: Teva Pharmaceuticals (TEVA) and Israel Chemical. Together, these two holdings represent over one-third of its index. Their respective performances will do much of the driving here.

Losers

Market Vectors Junior Gold Miners ETF (GDXJ) -7.7%

Despite its reputation as a safe haven destination, gold prices have struggled in recent weeks. The metal's shaky action, combined with investor hesitance toward market-correlated sectors, has weighed on gold miner stocks.

Given its spurt of peculiar action recently, it will be interesting to see what is in store for gold in the days ahead.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,156.85 +24.88 0.15%
S&P 500 2,001.57 +2.59 0.13%
NASDAQ 4,562.1890 +9.43 0.21%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs